Synthesis and structure-activity relationships of 5-heteroatom-substituted pyridopyrimidines as adenosine kinase inhibitors
- 7 March 2003
- journal article
- Published by Elsevier BV in European Journal of Medicinal Chemistry
- Vol. 38 (3), 245-252
- https://doi.org/10.1016/s0223-5234(03)00019-9
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Discovery of 4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine, an Orally Active, Non-Nucleoside Adenosine Kinase InhibitorJournal of Medicinal Chemistry, 2001
- Structure–activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2000
- Purinergic and pyrimidinergic receptors as potential drug targetsBiochemical Pharmacology, 2000
- Therapeutic potential of adenosine kinase inhibitorsExpert Opinion on Investigational Drugs, 2000
- Spinal cord adenosine receptor stimulation in rats inhibits peripheral neutrophil accumulation. The role of N-methyl-D-aspartate receptors.JCI Insight, 1996
- Acadesine: Prototype adenosine regulating agent for treating myocardial ischemia‐reperfusion injuryDrug Development Research, 1993
- Adenosinergic approaches to stroke therapeuticsMedical Hypotheses, 1990
- Synthesis of 4‐methylthio‐2(1H)‐pyridone derivatives using ketene dithioacetalsJournal of Heterocyclic Chemistry, 1987